• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液透析治疗精神分裂症性精神病]

[The treatment of schizophrenic psychoses with hemodialysis].

作者信息

Neumann N U

出版信息

Fortschr Med. 1979 Apr 12;97(14):654-5, 657.

PMID:437634
Abstract

A very controversial debate, concerning the treatment of schizophrenic psychoses by means of hemodialysis, started approximately in 1977, when American scientists reported outstanding successes with this method. Until now there is no clear evidence of the underlying principle of effectiveness of this method. According to present experiences there are three theories. Already in 1960 there were reports of successful application of hemodialysis in acute schizophrenic psychoses. The authors, among other things, assumed the filtration of a toxic blood substance to be the therapeutic principle. Later, however, changes in the blood circulation during dialysis, especially the improvement of cerebral perfusion, were seen as the real therapeutic factor. The recently reported findings of abnormal endorphin in the dialysate fluid of schizophrenics, brought back the theory of detoxification. At the same time there were claims by different authors, that the positive results were only due to a "changed psychological situation" of the treated patients. Which of these three theories is correct can not be decided yet. Whether blood purification methods have anything to offer for the treatment of some types of schizophrenic diseases requires further research.

摘要

一场关于通过血液透析治疗精神分裂症性精神病的极具争议的辩论大约始于1977年,当时美国科学家报告了这种方法取得的显著成功。到目前为止,尚无明确证据证明该方法有效性的潜在原理。根据目前的经验,有三种理论。早在1960年就有关于血液透析成功应用于急性精神分裂症性精神病的报道。作者们认为,除其他外,血液中有毒物质的滤过是治疗原理。然而,后来透析过程中的血液循环变化,尤其是脑灌注的改善,被视为真正的治疗因素。最近报道的精神分裂症患者透析液中内啡肽异常的发现,使解毒理论再度兴起。与此同时,不同作者声称,积极结果仅仅是由于接受治疗的患者“心理状况改变”。这三种理论中哪一种正确尚无法确定。血液净化方法是否能为某些类型的精神分裂症疾病的治疗提供帮助,还需要进一步研究。

相似文献

1
[The treatment of schizophrenic psychoses with hemodialysis].[血液透析治疗精神分裂症性精神病]
Fortschr Med. 1979 Apr 12;97(14):654-5, 657.
2
Hemodialysis in the treatment of a group of schizophrenic patients.
Acta Psychiatr Scand Suppl. 1985;321:1-127.
3
[Classification of schizophrenic psychoses].[精神分裂症性精神病的分类]
Fortschr Neurol Psychiatr. 1983 Sep;51(9):295-312. doi: 10.1055/s-2007-1002235.
4
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
5
[Hemodialysis in patients with chronic schizophrenia (author's transl)].慢性精神分裂症患者的血液透析(作者译)
Fortschr Neurol Psychiatr Grenzgeb. 1980 Jul;48(7):393-400. doi: 10.1055/s-2007-1002392.
6
Some recent biochemical findings with possible therapeutic implications for schizophrenia.一些近期的生化研究发现,可能对精神分裂症有治疗意义。
J Clin Psychiatry. 1978 Jun;39(6):535-6, 541.
7
[Psychopathology of schizophrenia and brain imaging].[精神分裂症的精神病理学与脑成像]
Fortschr Neurol Psychiatr. 2008 May;76 Suppl 1:S49-56. doi: 10.1055/s-2008-1038152.
8
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
9
[Overall results of attempts to treat schizophrenia by hemodialysis. Reflections on the placebo effect in a psychosis].[血液透析治疗精神分裂症的尝试的总体结果。关于精神病中安慰剂效应的思考]
Acta Psychiatr Belg. 1986 May-Jun;86(3):266-86.
10
[Cerebrospinal fluid filtration as experimental therapy in therapy refractory psychoses in Borna disease virus seropositive patients. Therapeutic effects, findings].
Psychiatr Prax. 2003 May;30 Suppl 2:S216-20.